跳至主要内容
临床试验/NCT00140764
NCT00140764已完成3 期

Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi

Johns Hopkins Bloomberg School of Public Health0 个研究点开始时间: 2003年1月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
主要终点
Prevalence of bacterial vaginosis

研究概览

简要总结

The purpose of this intervention is to find out whether intravaginal treatment with a gel containing an antibiotic (metronidazole), compared to a similar placebo gel (without antibiotic), can reduce the frequency of bacterial vaginosis, a common vaginal infection among African women who are HIV uninfected or HIV infected. The study will also determine the effect of these vaginal gels on genitourinary symptoms.

详细描述

This is a phase 3, randomized, double masked, two arms study conducted in Malawi, Southeast Africa. The study is conducted among nonpregnant HIV infected or uninfected women of reproductive age. Intermittent mass treatment approaches are followed where women are randomized to antibiotic intravaginal treatment or placebo at enrollment. Women receive assigned product every three months for one year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Nonpregnant HIV-Uninfected HIV-Infected

排除标准

  • 未提供

结局指标

主要结局

Prevalence of bacterial vaginosis

Reported genitourinary symptoms

次要结局

未报告次要终点

研究者

相似试验

Intravaginal Treatment of Disturbances of Vaginal... | 临床试验